Novo Nordisk A/S
This PhD position focuses on developing automated, reproducible bioanalysis methods using aptamers to reduce reliance on animal-derived reagents in pharmaceutical assays. The role involves generating and characterizing DNA/RNA-based aptamers, optimizing bioanalytical methods, and benchmarking new formats against established techniques. The candidate will work across Aarhus University and Novo Nordisk, contributing to scientific discovery and regulatory compliance in drug development.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Postdoctoral Research Fellow - DNA/Aptamer Chemist
The University of British Columbia
Senior Associate Scientist - Bioanalysis
Regeneron Pharmaceuticals
PK Bioanalysis Director
Exelixis
Research Associate I/II, Cloning/IVT (Contract)
Terrana Biosciences, Inc.
Research Associate I/II, Cloning/IVT (Contract)
Terrana Biosciences, Inc.
Senior Scientist II (Preclinical Bioanalysis)
Exelixis